# Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients

> **NCT02408185** · PHASE1 · COMPLETED · sponsor: **Fundación Pública Andaluza para la gestión de la Investigación en Sevilla** · enrollment: 20 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DRUG:** Colistin 6 million units + 240mg/8h
- **DRUG:** Colistin 6 million units + 360mg/12h

## Key facts

- **NCT ID:** NCT02408185
- **Lead sponsor:** Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408185, "Optimization Dose Study on Pharmacokinetics and Pharmacodynamics of Colistin in Critically Ill Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02408185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*